Anticorps Monoclonal anti-FXN

FXN Monoclonal Antibody for Cytometric bead array, Sandwich ELISA, Indirect ELISA, Sample test

Hôte / Isotype

Mouse / Ig2b

Réactivité testée

Humain

Applications

Cytometric bead array, Sandwich ELISA, Indirect ELISA, Sample test

Conjugaison

Non conjugué

CloneNo.

4B5D3

N° de cat : 68925-3-PBS

Synonymes

Extramitochondrial frataxin, EC:1.16.3.1, dFXN, d FXN, CyaY

---

Galerie de données de validation

• 

  Sandwich ELISA standard curve of MP50628-1

  Sandwich ELISA standard curve of MP50628-1, Human FXN Monoclonal Matched Antibody Pair - PBS only. 68925-2-PBS was coated to a plate as the capture antibody and incubated with serial dilutions of standard Ag6632. 68925-3-PBS was HRP conjugated as the detection antibody. Range: 0.313-20 ng/mL

• 

  Sample test of MP50628-1

  The mean FXN concentration was determined to be 246.06 ng/mL in HL-60 cell extract based on a 1.4 mg/mL extract load, 46.90 ng/mL in MCF-7 cell extract based on a 1.2 mg/mL extract load and 476.28 ng/mL in HepG2 cell extract based on a 1.0 mg/mL extract load.

• 

  Cytometric bead array standard curve of MP50628-1

  Cytometric bead array standard curve of MP50628-1, FXN Monoclonal Matched Antibody Pair, PBS Only. Capture antibody: 68925-2-PBS. Detection antibody: 68925-3-PBS. Standard:Ag6632. Range: 0.098-100 ng/mL.

---

Informations sur le produit

68925-3-PBS cible FXN dans les applications de Cytometric bead array, Sandwich ELISA, Indirect ELISA, Sample test et montre une réactivité avec des échantillons Humain

• Réactivité: Humain
• Hôte / Isotype: Mouse / Ig2b
• Clonalité: Monoclonal
• Type: Anticorps
• Immunogène: FXN Protéine recombinante Ag6632
• Nom complet: frataxin
• Masse moléculaire calculée: 23 kDa
• Numéro d’acquisition GenBank: BC048097
• Symbole du gène: FXN
• Identification du gène (NCBI): 2395
• Conjugaison: Non conjugué
• Forme: Liquide
• Méthode de purification: Protein A Magarose purification
• Tampon de stockage: PBS only
• Conditions de stockage: Store at -80°C. 20ul contiennent 0,1% de BSA.

{{ptg:RelatedPrimaryAntibodies}}